Although several previous studies have documented the clinical significance of EphA1 in a variety of malignant tumors including, pancreatic, breast, colorectal, urothelial, vulvar and non-melanoma skin carcinoma[16,18,24-27], we did not find any significant associations with clinicopathological parameters and patients’ survival. This evidence concerns the gene EPHA1 and non-melanoma skin carcinoma.